Aigen Investment Management’s Revolution Medicines RVMD Stock Holding History

Aigen Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$245K	Buy	+1,307	New	+$191K	0.07%	370
2026 Q1	–	Sell	-8,129	Closed	-$647K	–	755
2025 Q4	$647K	Sell	8,129 -11,117	-58%	-$729K	0.15%	207
2025 Q3	$899K	Buy	19,246 +4,621	+32%	+$181K	0.14%	227
2025 Q2	$538K	Buy	14,625 +2,701	+23%	+$104K	0.07%	387
2025 Q1	$422K	Buy	+11,924	New	+$484K	0.07%	395
2024 Q3	–	Sell	-8,660	Closed	-$336K	–	974
2024 Q2	$336K	Buy	+8,660	New	+$324K	0.07%	440
2023 Q4	–	Sell	-21,071	Closed	-$583K	–	1043
2023 Q3	$583K	Buy	+21,071	New	+$625K	0.11%	307

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Aigen Investment Management's RVMD Position: Q2 2026 in Review

Aigen Investment Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 1,307 shares worth $245K. The stake represents 0.07% of the portfolio and ranks #370 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in RVMD as recently as Q4 2025.

Aigen Investment Management first reported a position in RVMD in Q3 2023 and has held it in 7 quarters since. The position peaked at $899K in Q3 2025. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Aigen Investment Management held 1,307 shares of Revolution Medicines worth $245K as of Q2 2026.
Revolution Medicines was a new Aigen Investment Management position in Q2 2026.
Revolution Medicines made up 0.07% of Aigen Investment Management's portfolio in Q2 2026, its #370 holding.
Aigen Investment Management first reported a position in Revolution Medicines in Q3 2023 and has held it in 7 quarters since.
Aigen Investment Management's Revolution Medicines position peaked at $899K in Q3 2025.
694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.